Last reviewed · How we verify
Bladder muscle dysfunction - overactive
Approved treatments
- Detrol · Upjohn
Detrol works by blocking the action of a chemical called acetylcholine at the muscarinic receptors in the bladder muscle. - Myrbetriq · Apgdi
Myrbetriq works by activating the beta-3 adrenergic receptor in the bladder muscle, leading to relaxation and improved bladder control. - Sanctura · AbbVie
Sanctura works by blocking the action of a chemical called acetylcholine at the M3 receptor in the bladder muscle, reducing muscle contractions and urgency. - Vesicare · University of California, Irvine
- Butyn
- Uritos
- Toviaz · Pfizer
- Toviaz · Pfizer
- Vesicare · Astellas Pharma
Vesicare works by blocking the action of a chemical called acetylcholine at the muscarinic receptors in the bladder muscle, reducing muscle contractions and urgency. - Enablex · AbbVie
Enablex works by blocking the action of a chemical called acetylcholine on the bladder muscle, which helps to relax the muscle and improve bladder control. - Ditropan Xl · Hisamitsu Pharmaceutical Co., Inc.
Oxybutynin works by blocking the action of a chemical called acetylcholine on the bladder muscle, reducing spasms and urgency. - Oxytrol · Jewish General Hospital
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Bladder muscle dysfunction - overactive patent landscape — cliff calendar, originator estates, attackable patents
- Bladder muscle dysfunction - overactive treatment landscape brief
- Bladder muscle dysfunction - overactive treatment updates RSS
Frequently asked questions about Bladder muscle dysfunction - overactive
What drugs treat Bladder muscle dysfunction - overactive?
Tracked treatments include Detrol, Myrbetriq, Sanctura, Vesicare, Butyn, Uritos, Toviaz, Enablex.
What is the treatment for Bladder muscle dysfunction - overactive?
Standard treatment for Bladder muscle dysfunction - overactive includes Detrol, Myrbetriq, Sanctura, Vesicare, Butyn. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Bladder muscle dysfunction - overactive patent cliff · Bladder muscle dysfunction - overactive CI report
- Treatment: Detrol · Upjohn
- Treatment: Myrbetriq · Apgdi
- Treatment: Sanctura · AbbVie
- Treatment: Vesicare · University of California, Irvine
- Treatment: Butyn
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing